Loading comparison

Beam Therapeutics vs Scribe Therapeutics

Base-editing platform that rewrites single DNA letters precisely, without making double-strand breaks.

Molecular-engineering platform that builds CRISPR enzymes from the ground up and licenses them for in vivo gene editing.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Founding

50% off

/month

90 of 100 spots left

Full

$10

/month

Available once all 100 Founding Member spots are claimed.

Get full access

Already subscribed? Sign in →